US11690850B2

Inhibitors of receptor interacting protein kinase I for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: November 26, 2019
Filing date: November 19, 2020
Grant date: July 04, 2023
Publication date: July 04, 2023
Language: en
PDF source: https://patentimages.storage.googleapis.com/2c/ba/46/99ca9f7a918d62/US11690850.pdf
Metadata fetched: August 29, 2026 00:30